A phase 1/2 study of talazoparib (BMN 673), an oral poly(ADP-ribose) polymerase inhibitor, plus temozolomide in children with refractory or recurrent malignancies: A Children's Oncology Group phase 1 consortium study (ADVL1411). (December 2016)

Record Type:: Journal Article
Title:: A phase 1/2 study of talazoparib (BMN 673), an oral poly(ADP-ribose) polymerase inhibitor, plus temozolomide in children with refractory or recurrent malignancies: A Children's Oncology Group phase 1 consortium study (ADVL1411). (December 2016)
Main Title:: A phase 1/2 study of talazoparib (BMN 673), an oral poly(ADP-ribose) polymerase inhibitor, plus temozolomide in children with refractory or recurrent malignancies: A Children's Oncology Group phase 1 consortium study (ADVL1411)
Authors:: Schafer, E.S.
Rau, R.E.
Liu, X.
Minard, C.G.
Reid, J.M.
Fox, E.
Weigel, B.J.
Blaney, S.M.
Abstract:
Is Part Of:: European journal of cancer. Volume 69(2016)supplement 1
Journal:: European journal of cancer
Issue:: Volume 69(2016)supplement 1
Issue Display:: Volume 69, Issue 2016 (2016)
Year:: 2016
Volume:: 69
Issue:: 2016
Issue Sort Value:: 2016-0069-2016-0000
Page Start:: S48
Page End:
Publication Date:: 2016-12
Subjects:: Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:: http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0959-8049(16)32728-9 ↗
Languages:: English
ISSNs:: 0959-8049
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 2630.xml